Baraboĭ V A, Ialkut S I, Savtsova Z D, Zinchenko V A, Zhukova V M, Zaritskaia M Iu
Radiats Biol Radioecol. 1994 Jul-Oct;34(4-5):663-70.
The antiradiation efficiency of low molecular thymic preparations (vilosen, thymogen) was determined. The therapeutic activity of thymic preparations is due to their influence on basic radiation injury syndromes (hemopoietic, gastrointestinal, immunodepressive). The protective mechanisms and perspectives of thymic preparations using in pathogenic therapy of radiation diseases are discussed.
测定了低分子胸腺制剂（维洛森、胸腺生成素）的抗辐射效率。胸腺制剂的治疗活性归因于它们对基本辐射损伤综合征（造血、胃肠道、免疫抑制）的影响。讨论了胸腺制剂在放射性疾病致病治疗中应用的保护机制及前景。
